Acute Lymphoblastic Leukemia, Adult

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

CAR T-cell Therapy in Patients With Renal Dysfunction

Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL

Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL

Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR

Determining the Mechanisms of Loss of CAR T Cell Persistence

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO

TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies

Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia

Study in Adult Ph-positive ALL

Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia